Close Menu

While Decode Genetics was able to find many links between genes and disease, "what it didn't find, however, was a business model that made sense," says this Newsweek article, and Decode went bankrupt in November. The company, however, is trying to rise from the ashes with an investment from Saga. The new CEO, Earl Collier is trying to turn Decode into a consulting company that would analyze researchers' sequencing data and "[give] it back in a nicely packaged way."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.